Futures on the Dow were significantly worse than the S&P
500 because of a cardiovascular drug’s late-stage setback.

Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
Futures on the Dow were significantly worse than the S&P
500 because of a cardiovascular drug’s late-stage setback.